Skip to main content
. 2023 Oct 5;29(3):e372–e381. doi: 10.1093/oncolo/oyad273

Figure 1.

Figure 1.

DCR, PFS, and OS according to LIPID score in patients treated with ICI (as monotherapy or combination with chemotherapy or target therapy). Abbreviations: DCR: disease control rate; PFS: progression-free survival; OS: overall survival; LIPID score: good risk (GR) group with TC ≥ 200 mg/dl and TG < 150 mg/dl, intermediate risk (IR) group with TC < 200 mg/dl and TG < 150 mg/dl or TC ≥ 200 mg/dl and TG ≥ 150 mg/dl, poor risk (PR) group with TC < 200 mg/dl and TG ≥150 mg/dl.